InvestorsHub Logo
Followers 22
Posts 3725
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Monday, 10/26/2020 7:31:58 AM

Monday, October 26, 2020 7:31:58 AM

Post# of 8789
Revance price target raised to $38 from $35 at Barclays. RVNC Barclays analyst Balaji Prasad raised the firm's price target on Revance to $38 from $35 and keeps an Overweight rating on the shares. The analyst expects to see signs of a broader recovery in Q3 for the U.S. Specialty Pharmaceuticals companies.

Read more at:
https://thefly.com/n.php?id=3181303
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News